Albendazole Sulfoxide-d7 (CAS 54029-12-8 unlabeled)
QUICK LINKS
Albendazole sulfoxide-d7 (Ricobendazole-d7) is the deuterium labeled Albendazole sulfoxide. Albendazole sulfoxide (Ricobendazole), the main active metabolite of Albendazole, exhibits anti-parasite effects. Deuterium has a stronger bond with carbon than hydrogen, which can lead to increased metabolic stability of the compound. This can be useful in kinetic studies to better understand how the compound behaves in biological samples over time. Deuterated compounds are often used as internal standards in mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. They help in accurately quantifying the concentration of compounds and their metabolites in biological samples by providing a comparison standard that behaves similarly to the non-deuterated compound but can be distinguished based on its mass or NMR signature.
Albendazole Sulfoxide-d7 (CAS 54029-12-8 unlabeled) References
- Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers. | Algorta, J., et al. 2022. Front Pharmacol. 13: 914886. PMID: 35910353
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Albendazole Sulfoxide-d7, 1 mg | sc-479897 | 1 mg | $388.00 |